Adult-onset eculizumab-resistant hemolytic uremic syndrome associated with cobalamin C deficiency

American Journal of Kidney Diseases

Volumn 63, Issue 1, 2014, Pages 119-123

  Cornec Le Gall, Emilie ^a   Delmas, Yahsou ^b   De Parscau, Loïc ^a   Doucet, Laurent ^a   Ogier, Hélène ^c   Benoist, Jean François ^c   Fremeaux Bacchi, Véronique ^d   Le Meur, Yannick ^a  

^a BREST UNIVERSITY HOSPITAL   (France)

^b University Hospital   (France)

^c HÔPITAL ROBERT DEBRÉ   (France)

^d HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; CYANOCOBALAMIN; ECULIZUMAB; HAPTOGLOBIN; HOMOCYSTEINE;

ADULT; ARTICLE; ASTHENIA; CASE REPORT; COBALAMIN C DEFICIENCY; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; GLOMERULUS FILTRATION RATE; HEMOLYSIS; HEMOLYTIC UREMIC SYNDROME; HUMAN; KIDNEY FAILURE; MALE; MALIGNANT HYPERTENSION; THROMBOTIC THROMBOCYTOPENIC PURPURA; VITAMIN BLOOD LEVEL; VITAMIN DEFICIENCY; YOUNG ADULT;

CHRONIC KIDNEY FAILURE; COBALAMIN; COBALAMIN C DISEASE; ECULIZUMAB; HEMOLYTIC UREMIC SYNDROME (HUS); MMACHC (METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA TYPE C PROTEIN);

ADULT; AMINO ACID METABOLISM, INBORN ERRORS; ANTIBODIES, MONOCLONAL, HUMANIZED; BETAINE; BIOPSY; CARRIER PROTEINS; DIAGNOSIS, DIFFERENTIAL; DRUG RESISTANCE; HOMOCYSTEINE; HOMOCYSTINURIA; HUMANS; HYDROXOCOBALAMIN; HYPERTENSION, MALIGNANT; IMMUNOLOGIC FACTORS; KIDNEY; KIDNEY FUNCTION TESTS; LEUCOVORIN; LIPOTROPIC AGENTS; MALE; METHIONINE; METHYLMALONIC ACID; MUTATION; RECURRENCE; RENAL DIALYSIS; TREATMENT OUTCOME; VITAMIN B COMPLEX;

EID: 84896514393     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2013.08.031     Document Type: Article

References (21)

1. C. Loirat, J. Saland, and M. Bitzan Management of hemolytic uremic syndrome Presse Med 41 3, pt 2 2012 e115 e135
2. J.P. Lerner-Ellis, J.C. Tirone, and P.D. Pawelek et al. Identification of the gene responsible for methylmalonic aciduria and homocystinuria, cblC type Nat Genet 38 1 2006 93 100
3. N. Carrillo-Carrasco, R.J. Chandler, and C.P. Venditti Combined methylmalonic acidemia and homocystinuria, cblC type. I. Clinical presentations, diagnosis and management J Inherit Metab Dis 35 1 2012 91 102
4. D.S. Rosenblatt, A.L. Aspler, M.I. Shevell, B.A. Pletcher, W.A. Fenton, and M.R. Seashore Clinical heterogeneity and prognosis in combined methylmalonic aciduria and homocystinuria (cblC) J Inherit Metab Dis 20 4 1997 528 538
5. J.P. Lerner-Ellis, N. Anastasio, and J. Liu et al. Spectrum of mutations in MMACHC, allelic expression, and evidence for genotype-phenotype correlations Hum Mutat 30 7 2009 1072 1081
6. A.C.-H. Tsai, C.F. Morel, and G. Scharer et al. Late-onset combined homocystinuria and methylmalonic aciduria (cblC) and neuropsychiatric disturbance Am J Med Genet A 143A 20 2007 2430 2434
7. C. Thauvin-Robinet, E. Roze, and G. Couvreur et al. The adolescent and adult form of cobalamin C disease: clinical and molecular spectrum J Neurol Neurosurg Psychiatr 79 6 2008 725 728
8. M.T. Geraghty, E.J. Perlman, and L.S. Martin et al. Cobalamin C defect associated with hemolytic-uremic syndrome J Pediatr 120 6 1992 934 937
9. T. Kind, J. Levy, M. Lee, S. Kaicker, J.F. Nicholson, and S.A. Kane Cobalamin C disease presenting as hemolytic-uremic syndrome in the neonatal period J Pediatr Hematol Oncol 24 4 2002 327 329
10. V. Guigonis, V. Frémeaux-Bacchi, and S. Giraudier et al. Late-onset thrombocytic microangiopathy caused by cblC disease: association with a factor H mutation Am J Kidney Dis 45 3 2005 588 595
11. J.L.K. Van Hove, R. Van Damme-Lombaerts, and S. Grünewald et al. Cobalamin disorder Cbl-C presenting with late-onset thrombotic microangiopathy Am J Med Genet 111 2 2002 195 201
12. A.P. Sharma, C.R. Greenberg, A.N. Prasad, and C. Prasad Hemolytic uremic syndrome (HUS) secondary to cobalamin C (cblC) disorder Pediatr Nephrol 22 12 2007 2097 2103
13. C. Nogueira, C. Aiello, and R. Cerone et al. Spectrum of MMACHC mutations in Italian and Portuguese patients with combined methylmalonic aciduria and homocystinuria, cblC type Mol Genet Metab 93 4 2008 475 480
14. J.P. Lerner-Ellis, J.C. Tirone, and P.D. Pawelek et al. Identification of the gene responsible for methylmalonic aciduria and homocystinuria, cblC type Nat Genet 38 1 2006 93 100
15. A.L. Boxer, J.H. Kramer, K. Johnston, J. Goldman, R. Finley, and B.L. Miller Executive dysfunction in hyperhomocystinemia responds to homocysteine-lowering treatment Neurology 64 8 2005 1431 1434
16. C.F. Morel, J.P. Lerner-Ellis, and D.S. Rosenblatt Combined methylmalonic aciduria and homocystinuria (cblC): phenotype-genotype correlations and ethnic-specific observations Mol Genet Metab 88 4 2006 315 321
17. C. Loirat, and V. Frémeaux-Bacchi Atypical hemolytic uremic syndrome Orphanet J Rare Dis 6 2011 60
18. J. Zuber, F. Fakhouri, L.T. Roumenina, C. Loirat, and V. Frémeaux-Bacchi Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies Nat Rev Nephrol 8 11 2012 643 657
19. V. Fremeaux-Bacchi, F. Fakhouri, and A. Garnier et al. Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults Clin J Am Soc Nephrol 8 4 2013 554 562
20. C.B. Brady, J.M. Gaziano, and R.A. Cxypoliski et al. Homocysteine lowering and cognition in CKD: the VA Homocysteine Study Am J Kidney Dis 54 3 2009 440 449
21. R.L. Jamison, P. Hartigan, and J.S. Kaufman et al. Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial JAMA 298 10 2007 1163 1170